Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Bhansali Engineering and Tatva Chintan Pharma Report Strong Q1 Earnings Growth

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Bhansali Engineering and Tatva Chintan Pharma Report Strong Q1 Earnings Growth

Analysed 20 Jul 2026·3 sources analysed·India·Business
Bhansali Engineering and Tatva Chintan Pharma Report Strong Q1 Earnings GrowthPreviousNext

Bhansali Engineering Polymers reported a 43% year-on-year rise in Q1 FY27 net profit to Rs 65.60 crore, with revenue increasing 53% to Rs 472.15 crore, driven by higher realizations and cost efficiencies. Tatva Chintan Pharma Chem's Q1 net profit more than doubled to Rs 15.98 crore, with revenue up 43% to Rs 167.05 crore, supported by growth across specialty chemical segments. Both companies showed improved profitability and operational performance in the June 2026 quarter.

Sentiment
71%
TBN's observations

First-hand measurement across 3 sources

We measured how 3 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (71/100). Lens Score 35/100.

Outlets measured: businessstandard, businessstandard, businessstandard. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 3 sources · Published under editorial oversight by The Balanced News
Analysed 20 Jul 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (71/100)

Sentiment was consistent across outlets (68–74/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

businessstandard broke this story on 20 Jul, 03:40 am. Other outlets followed.

20 Jul, 03:40 am3 sources · 89 min20 Jul, 05:10 am
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
ATMS Advisors LLP Joins AGN International to Enhance Cross-Border Advisory Services
Next →
Nearly 3 in 10 Pakistanis Live Below Poverty Line Amid Economic Challenges
  1. 1
    businessstandard20 Jul, 03:40 am
    Bhansali Engineering Polymers consolidated net profit rises 42.95 in the June 2026 quarter
  2. 2
    businessstandard20 Jul, 05:10 am
    Tatva Chintan Pharma rallies after Q1 PAT jumps more than two-fold
  3. 3
    businessstandard20 Jul, 05:10 am
    Bhansali Engineering Polymers jumps as Q1 PAT rises 43 YoY

Who's involved

Institutions and figures named across source coverage.

Corporate
Tatva Chintan Pharma ChemBhansali Engineering Polymers

Story context

Category
Business
Location
India
Sources analysed
3
Last analysed
20 Jul 2026
Key entities
CroreIndian rupeePolymerNet incomeRevenuePharmaceutical industryAxis BankIDBI BankICICI BankEarnings before interest, taxes, depreciation, and amortizationHDFC BankLeverage (finance)